vs

Side-by-side financial comparison of BICYCLE THERAPEUTICS PLC (BCYC) and Black Rock Coffee Bar, Inc. (BRCB). Click either name above to swap in a different company.

Black Rock Coffee Bar, Inc. is the larger business by last-quarter revenue ($51.5M vs $48.0M, roughly 1.1× BICYCLE THERAPEUTICS PLC). Black Rock Coffee Bar, Inc. runs the higher net margin — -1.4% vs -42.0%, a 40.6% gap on every dollar of revenue. BICYCLE THERAPEUTICS PLC produced more free cash flow last quarter ($-19.9M vs $-25.8M).

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical firm developing innovative bicyclic peptide therapies for unmet medical needs. Its core pipeline covers oncology, rare diseases, and immunological disorders, with operations in Europe and North America, and partnerships with global pharma leaders to advance drug candidates to market.

Black Rock Coffee Bar, Inc. is a U.S.-based specialty coffee retail chain that offers handcrafted premium coffee beverages, energy drinks, baked goods, and light snacks. It operates in-store and drive-thru locations primarily across western U.S. states, prioritizing high-quality customizable products and community-focused consumer experiences.

BCYC vs BRCB — Head-to-Head

Bigger by revenue
BRCB
BRCB
1.1× larger
BRCB
$51.5M
$48.0M
BCYC
Higher net margin
BRCB
BRCB
40.6% more per $
BRCB
-1.4%
-42.0%
BCYC
More free cash flow
BCYC
BCYC
$5.9M more FCF
BCYC
$-19.9M
$-25.8M
BRCB

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
BCYC
BCYC
BRCB
BRCB
Revenue
$48.0M
$51.5M
Net Profit
$-20.2M
$-712.0K
Gross Margin
Operating Margin
-51.5%
-12.4%
Net Margin
-42.0%
-1.4%
Revenue YoY
1193.3%
Net Profit YoY
61.1%
EPS (diluted)
$-0.29
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BCYC
BCYC
BRCB
BRCB
Q4 25
$48.0M
Q3 25
$11.7M
$51.5M
Q2 25
$2.9M
Q1 25
$10.0M
Q4 24
$3.7M
Q3 24
$2.7M
Q2 24
$9.4M
Q1 24
$19.5M
Net Profit
BCYC
BCYC
BRCB
BRCB
Q4 25
$-20.2M
Q3 25
$-59.1M
$-712.0K
Q2 25
$-79.0M
Q1 25
$-60.8M
Q4 24
Q3 24
$-50.8M
Q2 24
$-39.8M
Q1 24
$-26.6M
Operating Margin
BCYC
BCYC
BRCB
BRCB
Q4 25
-51.5%
Q3 25
-558.6%
-12.4%
Q2 25
-2965.8%
Q1 25
-703.7%
Q4 24
Q3 24
-2385.9%
Q2 24
-498.3%
Q1 24
-162.4%
Net Margin
BCYC
BCYC
BRCB
BRCB
Q4 25
-42.0%
Q3 25
-503.7%
-1.4%
Q2 25
-2703.8%
Q1 25
-608.9%
Q4 24
Q3 24
-1898.4%
Q2 24
-425.3%
Q1 24
-136.0%
EPS (diluted)
BCYC
BCYC
BRCB
BRCB
Q4 25
$-0.29
Q3 25
$-0.85
$-0.05
Q2 25
$-1.14
Q1 25
$-0.88
Q4 24
Q3 24
$-0.74
Q2 24
$-0.77
Q1 24
$-0.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BCYC
BCYC
BRCB
BRCB
Cash + ST InvestmentsLiquidity on hand
$628.1M
$32.6M
Total DebtLower is stronger
$20.0M
Stockholders' EquityBook value
$610.0M
$43.0M
Total Assets
$717.6M
$323.2M
Debt / EquityLower = less leverage
0.46×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BCYC
BCYC
BRCB
BRCB
Q4 25
$628.1M
Q3 25
$648.3M
$32.6M
Q2 25
$721.5M
Q1 25
$793.0M
Q4 24
$879.5M
Q3 24
$890.9M
Q2 24
$961.4M
Q1 24
$457.0M
Total Debt
BCYC
BCYC
BRCB
BRCB
Q4 25
Q3 25
$20.0M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$30.9M
Q1 24
$30.8M
Stockholders' Equity
BCYC
BCYC
BRCB
BRCB
Q4 25
$610.0M
Q3 25
$618.5M
$43.0M
Q2 25
$668.9M
Q1 25
$740.3M
Q4 24
$793.1M
Q3 24
$831.0M
Q2 24
$873.8M
Q1 24
$356.0M
Total Assets
BCYC
BCYC
BRCB
BRCB
Q4 25
$717.6M
Q3 25
$764.0M
$323.2M
Q2 25
$832.2M
Q1 25
$883.9M
Q4 24
$956.9M
Q3 24
$996.7M
Q2 24
$1.1B
Q1 24
$547.1M
Debt / Equity
BCYC
BCYC
BRCB
BRCB
Q4 25
Q3 25
0.46×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.04×
Q1 24
0.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BCYC
BCYC
BRCB
BRCB
Operating Cash FlowLast quarter
$-19.3M
$-2.9M
Free Cash FlowOCF − Capex
$-19.9M
$-25.8M
FCF MarginFCF / Revenue
-41.5%
-50.2%
Capex IntensityCapex / Revenue
1.2%
44.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-252.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BCYC
BCYC
BRCB
BRCB
Q4 25
$-19.3M
Q3 25
$-71.2M
$-2.9M
Q2 25
$-72.8M
Q1 25
$-86.4M
Q4 24
$-164.7M
Q3 24
$-39.8M
Q2 24
$-44.6M
Q1 24
$-70.9M
Free Cash Flow
BCYC
BCYC
BRCB
BRCB
Q4 25
$-19.9M
Q3 25
$-71.8M
$-25.8M
Q2 25
$-73.3M
Q1 25
$-87.0M
Q4 24
$-166.0M
Q3 24
$-40.3M
Q2 24
$-45.0M
Q1 24
$-70.9M
FCF Margin
BCYC
BCYC
BRCB
BRCB
Q4 25
-41.5%
Q3 25
-612.3%
-50.2%
Q2 25
-2509.7%
Q1 25
-871.7%
Q4 24
-4475.7%
Q3 24
-1504.7%
Q2 24
-481.2%
Q1 24
-362.9%
Capex Intensity
BCYC
BCYC
BRCB
BRCB
Q4 25
1.2%
Q3 25
5.7%
44.5%
Q2 25
17.1%
Q1 25
6.1%
Q4 24
33.3%
Q3 24
16.3%
Q2 24
4.5%
Q1 24
0.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons